Stimulation by neuropeptide Y of growth hormone secretion in prolactinoma in vivo

Neuropeptides

Volumn 30, Issue 5, 1996, Pages 429-432

  Watanobe, H ^a,c   Tamura, T ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE Y;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA;

EID: 0029973597     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90005-0     Document Type: Article

References (18)

1. Kalra SP, Crowley WR. Neuropeptide Y: a novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone. Front Neuroendocrinol 1992; 13: 1-46.
2. Watanobe H, Nigawara T, Anzai J et al. Neuropeptide Y potentiates the luteinizing hormone (LH) response to LH-releasing hormone in men. Biochem Blophys Res Commun 1994; 200: 1111-1117.
3. Adams EF, Venetikou MS, Woods CA, Lacoumenta S, Burrin JM. Neuropeptide Y directly inhibits growth hormone secretion by human pituitary somatotropic tumours. Acta Endocrinol 1987; 115: 149-154.
4. Reichlin S. Neuroendocrine significance of vasoactive intestinal polypeptide. Ann NY Acad Sci 1988; 527: 431-449.
5. Watanobe H, Sasaki S, Sone K, Takebe K. Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparision with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide. J Clin Endocrinol Metab 1991; 72: 982-985.
6. Watanobe H, Sasaki S, Takebe K. Failure to confirm a growth hormone-releasing activity of corticotropin-releasing hormone in acromegaly: comparison with the effects of other hypothalamic hormones. Acta Endocrinol 1991; 125: 487-490.
7. Watanobe H, Takebe K. A further study on the stimulatory effect of peptide histidine methionine on growth hormone secretion in acromegaly: a dose-related study and a comparison with vasoactive intestinal peptide. Neuropeptides 1992; 23: 115-119.
8. Watanobe H, Tamura T. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP. J Clin Endocrinol Metab 1994; 78: 1372-1377
9. Watanobe H, Tamura T. Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly. Neuropeptides 1995; 28: 115-124.
10. Chihara K, Kaji H, Minamitani N et al. Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly. J Clin Endocrinol Metab 1984; 58: 81-86.
11. Kato Y, Shimatsu A, Matsushita N, Ohta H, Imura H. Role of vasoactive intestinal polypeptide (VIP) in regulating the pituitary function in man. Peptides 1984; 5: 389-394.
12. Ambrosi B, Bochicchio D, Sartorio A, Morabito F, Faglia G. Vasoactive intestinal polypeptide enhances ACTH levels in some patients with adrenocorticotropin-secreting pituitary adenomas. Acta Endocrinol 1987; 116: 216-220.
13. Watanobe H, Tamura T, Takahashi K. Anomalous growth hormone response to vasoactive intestinal peptide and peptide histidine methionine in patients with prolactinoma or hypothalamic hyperprolactinemia. Neuropeptides 1994; 27: 137-142.
14. McDonald JK, Lumpkin MD, Samson WK, McCann SM. Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats. Proc Natl Acad Sci USA 1985; 82: 561-564.
15. Rettori V, Milenkovic L, Aguila MC, McCann SM. Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. Endocrinology 1990; 126: 2296-2301.
16. Horvath TL, Shanabrough M, Naftolin F, Leranth C. Neuropeptide Y innervation of estrogen-induced progesterone receptor-containing dopamine cells in the monkey hypothalamus: a triple labeling light and electron microscopic study. Endocrinology 1993; 133: 405-414.
17. Everitt BJ, Meister B, Hoekfelt T et al. The hypothalamic arcuate nucleus median eminence complex: immunohistochemistry of transmitters, peptides and DARPP-32 with special reference to coexistence in dopamine neurons. Brain Res Rev 1986; 11: 97-155.
18. Kamegai J, Minami S, Sugihara H, Higuchi H, Wakabayashi I. Growth hormone induces expression of the c-fos gene on hypothalamic neuropeptide Y and somatostatin neurons in hypophysectomized rats. Endocrinology 1994; 135: 2765-2771.